After a Point-Blank Rejection Letter From the FDA, This Founder Went Back to the Drawing Board

Cindy Whitehead spent years working on a treatment for low sexual desire in women. When the FDA rejected her drug, she disputed the decision with the stories of affected women — and won.

Leave a comment

Your email address will not be published. Required fields are marked *